Scholarly Index
Hongliang Li
Jiangnan University; 27,915 total citations; 457 total publications; best world rank #73
Jiangnan University
27,915Total citations
457Total publications
79H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cardiac Fibrosis and Remodeling | Lifetime | 73 | CN 4 | 98.68 |
| Signaling Pathways in Disease | Lifetime | 177 | CN 8 | 97.84 |
| interferon and immune responses | Lifetime | 591 | CN 51 | 96.43 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 822 | CN 34 | 95.29 |
| NF-κB Signaling Pathways | Lifetime | 659 | CN 46 | 94.63 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 642 | CN 84 | 97.17 |
| Diet, Metabolism, and Disease | 2021-2025 | 378 | CN 54 | 90.60 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 495 | CN 95 | 83.89 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 923 | CN 161 | 81.64 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 356 | CN 122 | 74.36 |
| Lipid metabolism and disorders | 2021-2025 | 477 | CN 115 | 71.54 |
| Signaling Pathways in Disease | 2021-2025 | 425 | CN 170 | 62.87 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 670 | CN 156 | 60.43 |